[{"data": {"name": "Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Dan Atar", "@type": "Person"}, {"name": "Christoph Bode", "@type": "Person"}, {"name": "Andr\u00e9 Stuerzenbecher", "@type": "Person"}, {"name": "Freek W. A. Verheugt", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4282426?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/fcp.12063", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCco4DisM1dCd-CTrdeEKDQv1bq-CDUcsSRLbT7FP-CREXkQZzQ9t8i", "propertyID": "ISCC"}], "datePublished": "2014-03-10"}, "schema": "schema.org", "mediatype": "application/ld+json"}]